Curriculum-Based Online and Live Activities


Course Director
Jerry Nick, MD
National Jewish Health
University of Colorado
Denver, Colorado

Curriculum Description

Approved and emerging treatment options, which directly correct cystic fibrosis transmembrane regulator loss-of-function alleles, have begun to change the management of patients with cystic fibrosis. Their use can lead to more effective, safer, and increasingly personalized therapy, as well as improved lung function, for patients with cystic fibrosis.

Through this curriculum, we hope to provide pulmonologists, pediatricians, nurses, and pharmacists with the necessary knowledge and skill to integrate these novel strategies into patient care and examine the role of these agents in the clinical setting. Join leading expert Dr. Jerry Nick for this engaging educational activity, and then register to have one of our experts join you on-site for an interactive discussion.

Target Audience

This activity has been designed to meet the educational needs of pulmonologists, pediatricians, registered nurses, advanced practice nurses, physician assistants, pharmacists, and other clinicians involved in the management of cystic fibrosis.